source
- J&J lines up $2.58B option to buy Sail, Flagship's in vivo CAR-T biotechThe in vivo CAR-T space is getting more competitive as one of the biggest cell therapy players expands its role. Johnson & Johnson is paying $785 million upfront to work with Flagship Pioneering's…Endpoints · 50m ago↗ source
- FTC sues Hims & Hers over alleged health data sharing and deceptive billing practicesThe Federal Trade Commission filed a lawsuit against Hims & Hers, a telehealth company based in San Francisco, accusing it of improper handling of patient information. According to the complaint,…